Shu‐Cheng Wan

21 papers and 548 indexed citations i.

About

Shu‐Cheng Wan has authored 21 papers that have received a total of 548 indexed citations. This includes 10 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Oncology. The topics of these papers are Nanoplatforms for cancer theranostics (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Inflammasome and immune disorders (4 papers). Shu‐Cheng Wan is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Inflammasome and immune disorders (4 papers) and collaborates with scholars based in China, Hong Kong and DR Congo. Shu‐Cheng Wan's co-authors include Zhi‐Jun Sun, Qi‐Chao Yang, Shuo Wang, Zhi‐Zhong Wu and Hexiang Deng and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications

In The Last Decade

Rankless by CCL
2025